EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Engineering Circular RNA Vaccines

Zhongyan Zhang, Yuanlei Fu, Xiaoli Ju, Furong Zhang, Peng Zhang, Meilin He

Pathogens · 2024

DOI: 10.3390/pathogens13080692 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2024. Verfasst von Zhongyan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Yantai University, Yantai 264005, China. Hauptthemen laut MEDLINE: mRNA Vaccines, RNA, Circular. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Youth Innovation Team Plan of Shandong Province, Fundamental Research Projects of Science & Technology Innovation and Development Plan in Yantai City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered circular RNAs (circRNAs) are a class of single-stranded RNAs with head-to-tail covalently linked structures that integrate open reading frames (ORFs) and internal ribosome entry sites (IRESs) with the function of coding and expressing proteins. Compared to mRNA vaccines, circRNA vaccines offer a more improved method that is safe, stable, and simple to manufacture. With the rapid revelation of the biological functions of circRNA and the success of Severe Acute Respiratory Coronavirus Type II (SARS-CoV-2) mRNA vaccines, biopharmaceutical companies and researchers around the globe are attempting to develop more stable circRNA vaccines for illness prevention and treatment. Nevertheless, research on circRNA vaccines is still in its infancy, and more work and assessment are needed for their synthesis, delivery, and use. In this review, based on the current understanding of the molecular biological properties and immunotherapeutic mechanisms of circRNA, we summarize the current preparation methods of circRNA vaccines, including design, synthesis, purification, and identification. We discuss their delivery strategies and summarize the challenges facing the clinical application of circRNAs to provide references for circRNA vaccine-related research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

mRNA VaccinesRNA, CircularAnimalsHumansCOVID-19COVID-19 VaccinesSARS-CoV-2Vaccines, Synthetic

Stichwörter der Autor:innen

RNA deliveryRNA therapeuticscircular RNA vaccinescircularizationmRNA

Substanzen

COVID-19 VaccinesmRNA VaccinesRNA, CircularVaccines, Synthetic

Autor:innen und Institutionen

  • School of Pharmacy, Yantai University, Yantai 264005, China.
  • Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Yantai 264005, China.

Förderung

  • Natural Science Foundation of Shandong Province
  • Youth Innovation Team Plan of Shandong Province
  • Fundamental Research Projects of Science & Technology Innovation and Development Plan in Yantai City

Zitieren

APA

Zhang, Z., Fu, Y., Ju, X., Zhang, F., Zhang, P., & He, M. (2024). Advances in Engineering Circular RNA Vaccines. Pathogens. https://doi.org/10.3390/pathogens13080692

Vancouver

Zhang Z, Fu Y, Ju X, Zhang F, Zhang P, He M. Advances in Engineering Circular RNA Vaccines. Pathogens. 2024. doi:10.3390/pathogens13080692

BibTeX
@article{Zhang2024,
  author = {Zhang, Zhongyan and Fu, Yuanlei and Ju, Xiaoli and Zhang, Furong and Zhang, Peng and He, Meilin},
  title = {Advances in Engineering Circular RNA Vaccines},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13080692}
}
Kostenlos starten →